This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2002 Nov 23;325(7374):1188.

doi: 10.1136/bmj.325.7374.1188.

The changed image of botulinum toxin

PMID: 12446514
PMCID: PMC1124678
DOI: 10.1136/bmj.325.7374.1188

Editorial

The changed image of botulinum toxin

V Peter Misra. BMJ. 2002.

. 2002 Nov 23;325(7374):1188.

doi: 10.1136/bmj.325.7374.1188.

Author

PMID: 12446514
PMCID: PMC1124678
DOI: 10.1136/bmj.325.7374.1188

No abstract available

PubMed Disclaimer

Similar articles

Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
Bhidayasiri R, Cardoso F, Truong DD. Bhidayasiri R, et al. Eur J Neurol. 2006 Feb;13 Suppl 1:21-9. doi: 10.1111/j.1468-1331.2006.01441.x. Eur J Neurol. 2006. PMID: 16417594 Review.
Comparison of botulinum toxins A and B in the treatment of facial rhytides.
Sadick NS, Matarasso SL. Sadick NS, et al. Dermatol Clin. 2004 Apr;22(2):221-6. doi: 10.1016/s0733-8635(03)00040-8. Dermatol Clin. 2004. PMID: 15222583
Botulinum toxin for achalasia: to be or not to be?
Castell DO, Katzka DA. Castell DO, et al. Gastroenterology. 1996 May;110(5):1650-2. doi: 10.1053/gast.1996.v110.agast961650. Gastroenterology. 1996. PMID: 8613076 No abstract available.
Cosmetic botulinum toxin injections.
Carter SR, Seiff SR. Carter SR, et al. Int Ophthalmol Clin. 1997 Summer;37(3):69-79. doi: 10.1097/00004397-199703730-00006. Int Ophthalmol Clin. 1997. PMID: 9279643 Review. No abstract available.
Botox and Dysport are distinct.
Madaliński M. Madaliński M. Endoscopy. 2000 Jun;32(6):502-3. Endoscopy. 2000. PMID: 10863924 No abstract available.

See all similar articles

Cited by

Targeted secretion inhibitors-innovative protein therapeutics.
Keith F, John C. Keith F, et al. Toxins (Basel). 2010 Dec;2(12):2795-815. doi: 10.3390/toxins2122795. Epub 2010 Dec 3. Toxins (Basel). 2010. PMID: 22069575 Free PMC article. Review.

References

1. Jost WH, Kohl A. Botulinum toxin: evidence-based criteria in rare indications. J Neurol. 2001;248 suppl1:39–44. - PubMed
1. Poewe W, Entner T. Studies with Dysport® in cervical dystonia. In: Brin MF, Jankovic J, Hallett M, editors. Scientific and therapeutic aspects of botulinum toxin. Lippincott Williams and Wilkins, Philadelphia. 2002. pp. 365–369.
1. Klein AW. Complications and adverse reactions with the use of botulinum toxin. Dis Mon. 2002;48:336–356. - PubMed
1. Carruthers JA, Lowe NJ, Menter MA, Gibson J, Nordquist M, Mordaunt J, et al. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol. 2002;46:840–849. - PubMed
1. Lowe NJ, Yamauchi PS, Lask GP, Patnaik R, Iyer S. Efficacy and safety of botulinum toxin type a in the treatment of palmar hyperhidrosis: a double-blind, randomized, placebo-controlled study. Dermatol Surg. 2002;28:822–827. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources